Position
Creative Planning in Rigel Pharmaceuticals Inc
Back to the book · All holders of RIGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$164.7K$42.83 → $27.04
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10.4K | $446.8K | — | — | — | 0.0% |
| Q1 2026 | 13.7K | $371.3K | $27.04 | −$164.7K | $89.2K | 0.0% |